Stallion India Fluorochemicals Ltd

Meeting Details

• Date and time: 17 August 2026, 04:00 PM IST.
• Type and mode: Group earnings conference call (virtual).
• Event/organiser: ConfideLeap Partners-hosted Q1 FY27 earnings conference call.

Participants

• Key company participants: Managing Director & CEO.

Purpose

• Purpose: Discuss Q1 FY27 earnings and business performance.

Additional Notes

• Recording: The call was recorded.
• Transcript: Transcript uploaded on the company website.

Issue Overview

• Type: Rights issue of fully paid-up equity shares.
• Total issue size: Rs 363.93 crore; no undersubscription reported.
• Main objectives: land acquisition, manufacturing facility, issue-related expenses, general corporate purposes.
• Cost structure unchanged at Rs 363.93 crore with no revisions.
• Securities: equity shares; approvals from NSE and BSE obtained.

Utilisation of Proceeds

• Utilisation as per offer document: yes.
• Deviations: nil; no material deviations observed.
• Acquisition of land: partially utilised; payments made; balance to be funded.
• Construction facility: partially utilised; progress steady; 4-month delay due to design changes.
• Issue-related expenses: fully utilised in Q4 FY26.
• General Corporate Purpose: allocation contemplated; utilisation as of 30 Jun 2026 nil; board approval pending.
• Unutilised funds: Rs 171.02 crore as of 30 June 2026; parked in fixed deposits and bank accounts.

Governance and Compliance

• Approvals: requisite in-principle approvals from NSE and BSE obtained.
• Material events: no adverse events flagged; no regulatory actions reported.
• Compliance: CA certificate verified; Monitoring Agency reports nil deviations; no conflicts disclosed.

General Corporate Purpose (GCP)

• GCP allocation: Rs 7.83 crore proposed; utilisation is subject to board approval.
• Current GCP utilisation: none as of 30 Jun 2026; board approval for allocation pending.

Meeting Details

• Date and time: 17 August 2026, 04:00 PM IST.
• Type and mode: group earnings conference call, virtual.
• Event/organiser: Earnings Conference Call organized by Stallion India Fluorochemicals Limited.

Participants

• Key management participants not disclosed in the filing.

Purpose

• Discuss unaudited financial results for the quarter ended 30 June 2026.

Additional Notes

• Audio recording of the earnings call is being made available online.

Business overview

• Specialized refrigerant and industrial gases provider with four facilities across Khalapur, Ghiloth, Manesar, Panvel.
• Backward integration includes 10,000 MT R-32 plant at Bhilwara; EC secured.
• Khalapur enables 1,200 MT/year high-purity helium processing; strengthens helium portfolio.
• Mambattu, Andhra Pradesh, planned operations by end-FY26-27; expands South India distribution.
• Partnerships with Honeywell for HFOs, Daikin for sourcing/logistics; SOC helium sourcing.
• Listed on NSE and BSE; Stallion Enterprises acquired in slump sale (2023).

Operational highlights

• Khalapur facility commenced 1,200 MT/year helium debulking and blending.
• Mambattu facility planned by end-FY26-27; 7,200 MT/year HFC/HFO debulking and blending.
• Bhilwara R-32 plant: 10,000 MT capacity; commissioning targeted Oct 2026.
• EC for Bhilwara R-32 plant valid for 10 years.
• Strategic helium sourcing via SOC; strengthens global supply framework.

Financial performance

• FY25-26 total revenue: ₹43,412.30 lakh; YoY +14.40%.
• FY25-26 EBITDA: ₹6,134.74 lakh; YoY +23.34%.
• FY25-26 PBT: ₹5,897.96 lakh; YoY +39.02%.
• FY25-26 PAT: ₹4,384.11 lakh; YoY +35.61%.
• FY25-26 EPS: ₹5.34.

Capital structure & liquidity

• Net worth ₹68,060.35 lakh; total assets ₹73,704.16 lakh.
• Current borrowings ₹3,401.14 lakh; non-current borrowings ₹0.00.
• Cash & Bank Balance ₹43,366.89 lakh; total current liabilities ₹5,570.62 lakh.

Strategic priorities & outlook

• Target 30-35% revenue CAGR over three years; EBITDA margin uplift 3-4%.
• Capex focus on Bhilwara R-32 and Mambattu expansions; backward integration.
• Expand into HFOs and specialty gases; strengthen sourcing via Honeywell, Daikin.
• Expand East India and helium/semiconductor gas capabilities; commissioning Oct 2026.

Risks & governance

• Regulatory approvals and project timelines; mitigated by EC and phased execution.
• Helium supply dependency; mitigated by SOC tie-up and diversified sourcing.
• Execution risk of greenfield plants; addressed via milestone-based commissioning.
• Governance: NSE & BSE listing completed; board/management stable.

Governance & leadership

• Public listing achieved on NSE and BSE.
• Company Secretary & Compliance Officer: Govind Rao.

Financial highlights

• Total revenue rose 12.78% YoY to ₹124.68 crore in Q1 FY27.
• EBITDA rose 75.85% YoY to ₹25.27 crore.
• PBT rose 78.83% YoY to ₹24.79 crore.
• PAT rose 79.15% YoY to ₹18.57 crore.

Operational progress

• Khalapur high-purity helium facility completed; 1,200 MT/yr capacity; commercial ops next quarter.
• Mambattu facility progressing; operations expected between November and December 2026.
• 10,000 MT R-32 facility at Bhilwara progressing; completion targeted by December 2026.

Outlook and strategy

• Projected 30-35% revenue CAGR over three years; margins to improve by 3-4%.
• Backward integration and higher-value gases to lift EBITDA margins.

Meeting Details

• Date and time: Monday, 17 August 2026, 04:00 PM IST.
• Type/Mode: virtual earnings call (conference call).

Participants

• Key management speaker: MD & CEO.

Purpose

• Purpose: discuss Q1 FY 2026-27 results for quarter ended 30 June 2026.

Additional Notes

• Zoom webinar registration link provided; dial-in details enclosed.

Financial results and audit

• Unaudited quarterly results for quarter ended June 30, 2026 approved.
• Limited Review Report on results unmodified.
• Audit Committee recommended the results; Board approved.
• Secretarial Audit Report for year ended 31 March 2026 taken on record.
• Directors' Report, MD&A and Corporate Governance Report approved.
• Single segment: manufacturing of industrial gases; no Ind AS 108 segmentation.

AGM, governance and director changes

• Draft AGM Notice approved; AGM date 21 September 2026 at 4:00 PM.
• Book closure from 15 September to 21 September 2026.
• Regularization of Swati Ghosh from Additional Independent Director to Woman Independent Director proposed for AGM.

IPO proceeds and capital actions

• IPO proceeds revised utilization plan to acquire land at Khalapur, Maharashtra; differential cost ₹20.13 crore.
• Special Resolution passed May 30, 2026 to implement revised utilization plan.
• Unutilised IPO proceeds temporarily invested in bank deposits; funds held in IPO accounts.

Financial results and governance

• Unaudited financial results for the quarter ended 30 June 2026 approved; Limited Review Report unmodified.
• Audit Committee reviewed results on 12 Aug 2026; Board approved.
• Secretarial Audit Report for FY ended 31 March 2026 taken on record.
• Directors' Report, MD&A, and Corporate Governance Report for FY ended 31 March 2026 approved.
• Draft AGM Notice for 21 Sept 2026 at 4:00 PM approved; book closure 15–21 Sept 2026.
• Regularisation of Swati Ghosh from Additional Independent Director to Woman Independent Director placed for shareholders' approval.

IPO proceeds and utilisation

• Net IPO proceeds of INR 14,474.87 lakhs; IPO expenses INR 1,598 lakhs.
• Special resolution (30 May 2026) approved revised IPO utilization plan for land Khalapur.
• Differential cost of revised plan amounting to ₹20.13 crore.
• Unutilised IPO proceeds temporarily invested in fixed deposits and related accounts.
• Allocations include working capital, capex for semiconductor and gas debulking facilities, and general corporate purposes.

Meeting Details

• Date: 21 July 2026; time not disclosed.
• Type/Mode: Group investor meet; virtual.
• Organizer: Stallion India Fluorochemicals Limited.
• Purpose: Analyst/investor interaction scheduled.
• Key company participants: Company Secretary & Compliance Officer.
• Note: Schedule subject to change; changes will be intimated.
• No UPSI will be discussed.